- 
                                                    
                        
 
                        - 
                            
                        
 
                        - 
                            
                                Sequence
 
                                - GFLSILKKVLPKⓍJAHⓍK
 
                            
                         
                        - 
                            
                        
 
                        - 
                            
                                Original Sequence
 
                                - GFLSILKKVLPKVMAHMK
 
                            
                         
                        - 
                            
                                Source
 
                                - Synthetic construct
 
                            
                         - 
                    
 
                    
                 
             
            
            
                  
                
                    
                        - 
                            
                                Biological Activity
 
                                - Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal
 
                            
                         
                        - 
                            
                                
                                - Function: Antibacterial activity against Gram-positive and Gram-negative bacteria and Antifungal activity against Candida albicans.
 
                            
                         
                        - 
                            
                                Target Organism
 
                                - 
                                    
- [Ref.22526241] Gram-positive bacteria: Micrococcus luteus (MIC = 0.8 μM), Bacillus subtilis (MIC = 1.1 μM), Staphylococcus aureus (MIC = 10.8 μM);
 - Gram-negative bacteria: E.coli (MIC = 2.5 μM), Pseudomonas aeruginosa (MIC = 77 μM);
 - Fungi: Candida albicans (MIC = 30 μM).
 
                                 
                            
                         
                        - 
                            
                                Hemolytic Activity
 
                                - 
                                    
- [Ref.22526241] LC50 = 18.1 μM. Note: LC50 is the concentration of a peptide able to lyse 50% of human erthrocytes in the assay.
 
                                 
                            
                         
                        - 
                            
                                Cytotoxicity
 
                                - 
                                    No cytotoxicity information found in the reference(s) presented
                                
 
                            
                         
                    
             
                 
             
            
            
                
                
                    
                        - 
                            
                                Linear/Cyclic
 
                                - Cyclic (Stapled)
 
                            
                         
                        - 
                            
                                N-terminal Modification
 
                                - Free
 
                            
                         	
                        - 
                            
                                C-terminal Modification
 
                                - Amidation
 
                            
                         
                        - 
                            
                                Special Amino Acid and Stapling Position
 
                                - ①The J (position: 14) in sequence indicates norleucine. ②The Ⓧ (position: 13 and 17) indicates 2-(4'-pentenyl) alanine in the S configuration. ③Ⓧ (13) and Ⓧ (17) are cross-linked by hydrocarbon stapling.
 
                            
                         
                        - 
                            
                        
 				
                        - 
                            
                                Secondary Structure
 
                                - ①19% α-helical content in water.②66% α-helical content in 50% TFE. ③75% α-helical content in 8mM SDS.
 
                            
                         
                        - 
                            
                                Structure Description
 
                                - The CD spectra of the singly stapled peptides of the i, i + 4 type acquired in water show a slight increase (by 5 %) of helical content in the case of MEP-Ns-1, MEP-Ns-2 and LL-IIIs-3 compared to their unstapled precursors.
 
                            
                         
                        - 
                            
                            
                            
                            
                                   
                                - 
                                    There is no predicted structure for DRAMP21495.
                                
 
                            
                                  
                         
                
                    
             
           
	  
            
				    
					
						
						
							- Literature 1
 
			   				- 
			   					
				    				Title
 
				    				- Effect of hydrocarbon stapling on the properties of α-helical antimicrobial peptides isolated from the venom of hymenoptera
 
						    	
						     							
	    					- 
			   					
						   	
 
						   	- 
			   					
				    				Reference
 
				    				- Amino Acids. 2012 Nov;43(5):2047-58. doi: 10.1007/s00726-012-1283-1. Epub 2012 Apr 28.
 
						    	
			   				 
						   	- 
			   					
				    				Author
 
				    				- Hubert Chapuis, Jiřina Slaninová, Lucie Bednárová, Lenka Monincová, Miloš Buděšínský, Václav Čeřovský